ISBN-13: 9783211832769 / Angielski / Twarda / 1999 / 220 str.
ISBN-13: 9783211832769 / Angielski / Twarda / 1999 / 220 str.
Expert clinicians and basic scientists with a special interest in Park insonFs disease review the current state of science and clinical thera peutics of the disease. Therefore these articles represent an authorat ive review of the current state of knowledge regarding preclinical cou rse and symptomatology, subtypes with their impact on the pathology, g enetic alterations, novel mechanisms of neuronal cell death, diagnosti c tools and old and novel therapeutic approaches with respect to neuro protection and neuroregeneration in ParkinsonFs disease. Particular em phasis has been placed on a novel antiparkinsonian drug called budipin e with various modes of action also influencing altered non dopaminerg ic systems in ParkinsonFs disease. It is evident, that many questions on the cause, course and treatment of ParkinsonFs disease are still un answered and therefore the ideal way to treat a parkinsonian patient r emains to be defined.